Keros Therapeutics updates corporate presentation; no material new disclosures in filing

Keros Therapeutics, Inc.

Company furnished a corporate presentation dated March 2026 for investor meetings.
Presentation is available on Keros's website; no forward-looking statements or specific data excerpted.
No financial results, pipeline milestones, or guidance changes were disclosed in the filing text.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.